Short description
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Description
Navitor Pharmaceuticals is a developer of novel medicines designed to target specific nutrient-sensing proteins that selectively regulate mTORC1 activity to treat diseases. The company's medicines selectively modulate the activity of mTORC1, a master regulator of cell growth and metabolism, and unlock the therapeutic potential of the mTOR pathway by targeting the amino acid and other nutrient sensors that selectively regulate the activity of mTORC1, enabling healthcare practitioners to address a wide range of metabolic, neurodegenerative, autoimmune and musculoskeletal diseases.
It was founded in 2009 and headquartered in Cambridge, Massachusetts.
Total funding
$$43214321
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2009
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Nopepepe, Nopepepe, Noaccess, Noaccess, Cannot Access, Noaccess, Uh Ohhhh, No Way
Sign in for full access
Founders
Alan Crane, David Goldfarb, David Sabatini